Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Slow, Steady Tx Release
Author(s):
San Diego - The most current data from an open label trial show that hydroquinone 4 percent with retinol is an effective and safe option to treat melasma and post-inflammatory hyperpigmentation, according to Pearl Grimes, M.D., the study's principal investigator.
Related Videos
Related Content
